Impact of potential modifications to Alzheimer's disease clinical trials in response to disruption by COVID-19: a simulation study.
Alzforum,
Schneider LS, Qiu Y, Thomas RG, Evans C, Jacobs DM, Jin S, Kaye JA, LaCroix AZ, Messer K, Salmon DP, Sano M, Schafer K, Feldman…